Home » Stocks » RMD

ResMed Inc. (RMD)

Stock Price: $271.80 USD 2.07 (0.77%)
Updated Jul 30, 2021 4:00 PM EDT - Market closed
Market Cap 39.55B
Revenue (ttm) 3.09B
Net Income (ttm) 457.24M
Shares Out 145.51M
EPS (ttm) 3.13
PE Ratio 86.86
Forward PE 46.30
Dividend $1.56
Dividend Yield 0.57%
Trading Day July 30
Last Price $271.80
Previous Close $269.73
Change ($) 2.07
Change (%) 0.77%
Day's Open 268.96
Day's Range 267.80 - 272.75
Day's Volume 350,322
52-Week Range 164.77 - 272.75

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

ResMed (RMD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

2 days ago - Zacks Investment Research

ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 days ago - Zacks Investment Research

Don't overthink it -- buy companies with excellent financials and a long runway for growth.

Other stocks mentioned: RGEN, VEEV
1 week ago - The Motley Fool

As the craze for meme stocks fades away, investors should consider growth investing to generate big returns. Here are 7 growth stocks to buy today.

Other stocks mentioned: ALKS, ATR, PEXL, SMP, TPX, VIOG
1 week ago - InvestorPlace

SAN DIEGO, July 15, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2021 on Thursday, Au...

2 weeks ago - GlobeNewsWire

Snap up these three top stocks, WST, PAHC and RMD, which continue to show promise amid the pandemic and can turn out to be prudent investment choices.

Other stocks mentioned: PAHC, WST
3 weeks ago - Zacks Investment Research

If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.

Other stocks mentioned: DVA, IT, LSTR
4 weeks ago - Zacks Investment Research

Here we look at three stocks, MDRX, CERN and RMD, that investors can keep a watch on the back of their robust digital health prospects.

Other stocks mentioned: CERN, MDRX, NXGN
1 month ago - Zacks Investment Research

Investors are optimistic about ResMed (RMD) on solid digital health growth potential along with rising demand for masks and other accessories.

1 month ago - Zacks Investment Research

A competitor's misfortune could be a big opportunity for the medical device giant.

1 month ago - The Motley Fool

RMD stock is also up 179% from the levels of around $85 seen toward the end of 2017. The rise over the last three years or so is justified given the company's robust fundamentals.

Other stocks mentioned: PHG
1 month ago - Forbes

Although ResMed Inc's (NYSE:RMD) long-term outlook is positive, the market seems to have over-reacted to rival Koninklijke Philips NV's (NYSE:PHG) recall notification of certain sleep and respiratory ca...

1 month ago - Benzinga

The full U.S. launch of ResMed (RMD) AirSense 11 is expected any time in 2021, which might receive bigger market acceptance capitalizing on its current peer position.

Other stocks mentioned: PHG
1 month ago - Zacks Investment Research

ResMed (RMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

1 month ago - Zacks Investment Research

With the trading day about halfway over, the markets were trading sideways yet again, and it seems like the major averages may be stuck on this plateau.

Other stocks mentioned: RIDE
1 month ago - 24/7 Wall Street

Gambling can be fun, but growing sales and profits are what matter for long-term gains.

Other stocks mentioned: TTD
1 month ago - The Motley Fool

SAN DIEGO, June 02, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the Goldman S...

1 month ago - GlobeNewsWire

SAN DIEGO, May 25, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the William Bl...

2 months ago - GlobeNewsWire

Investors continue to be optimistic about ResMed (RMD), owing to its potential in digital health and consistent high demand for its masks.

2 months ago - Zacks Investment Research

Lower device sales including weak demand for ventilators due to COVID-19 hurt ResMed's (RMD) Q3 top line.

3 months ago - Zacks Investment Research

ResMed (RMD) delivered earnings and revenue surprises of 6.56% and -2.00%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

- Year-over-year operating profit up 3%, non-GAAP operating profit up 2%

3 months ago - GlobeNewsWire

SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie Australia Conference on Wedn...

3 months ago - GlobeNewsWire

Improvement in demand for Mask and Other accessories along with rapid adoption of digital health solution is likely to have contributed to ResMed's (RMD) Q3 growth.

3 months ago - Zacks Investment Research

ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

Well-known guidance from Warren Buffett can help us identify opportunities in an expensive market.

Other stocks mentioned: ALGN, VRTX
3 months ago - The Motley Fool

Cantel (CMD), Hill-Rom (HRC), LeMaitre (LMAT) and Masimo (MASI) can prove to be prudent investment choices in the critical care industry of the MedTech sector.

Other stocks mentioned: CMD, HRC, LMAT, MASI
3 months ago - Zacks Investment Research

Three stocks to have on your radar in the healthcare space.

Other stocks mentioned: INSP, VVOS
3 months ago - The Motley Fool

Nyxoah Reports Full Year 2020 Results

3 months ago - GlobeNewsWire

SAN DIEGO, April 08, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2021 on Thursday, Ap...

3 months ago - GlobeNewsWire

Here are some dirt-cheap MedTech value stocks - IVC, MCK, HRC - which are expected to provide long-term gains in 2021.

Other stocks mentioned: HRC, IVC, MCK, XENT
4 months ago - Zacks Investment Research

The stock of ResMed (NYSE:RMD, 30-year Financials) appears to be modestly overvalued, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the stoc...

4 months ago - GuruFocus

Investors continue to be optimistic about ResMed (RMD), owing to its potential in digital health and consistent high demand for its critical care products.

4 months ago - Zacks Investment Research

There are long-term implications to the coronavirus pandemic that the market is not appreciating.

Other stocks mentioned: AAPL, ABMD, AMZN, CVX, GILD, JNJ, MDT ...
4 months ago - The Motley Fool

MedTech stocks like INMD, BASI and SMLR are expected to maintain market-beating momentum in 2021.

Other stocks mentioned: BASI, DGX, HOLX, INMD, LH, SMLR
4 months ago - Zacks Investment Research

SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer and Brett Sandercock, chief financial officer, will participate in a virtual f...

4 months ago - Business Wire

SAN DIEGO--(BUSINESS WIRE)---- $RMD #sleep--ResMed's 2021 U.S. Consumer Sleep Survey reveals how many Americans have symptoms of a common sleep disorder, but aren't concerned about them.

4 months ago - Business Wire

These steady, strong healthcare stocks are great picks for investors to buy and hold onto for at least the next five years. The post 7 Healthcare Stocks to Buy and Hold for the Long Term appeared first ...

Other stocks mentioned: CMPS, ILMN, JNJ, PFE, TDOC, TMO
4 months ago - InvestorPlace

ResMed (RMD) reported earnings 30 days ago. What's next for the stock?

5 months ago - Zacks Investment Research

The market itself is sitting at lofty valuations, but several S&P 500 stocks are extremely overheated. Consider giving these 10 picks a little time to cool off.

Other stocks mentioned: ABMD, CMG, FTNT, ILMN, MSCI, ROL, TER ...
5 months ago - Kiplinger

PAHC vs. RMD: Which Stock Is the Better Value Option?

Other stocks mentioned: PAHC
5 months ago - Zacks Investment Research

ResMed (RMD) reported second-quarter fiscal 2021 revenues of $800 million, up 9% from a year ago.

6 months ago - Zacks Investment Research

ResMed Inc. (RMD) CEO Mick Farrell on Q2 2021 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

ResMed (RMD) delivered earnings and revenue surprises of 15.57% and 3.60%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Shares of ResMed (NYSE:RMD) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 16.53% year over year to $1.41, which beat the estimate of ...

6 months ago - Benzinga

SAN DIEGO--(BUSINESS WIRE)--ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading digital health company, today announced results for its quarter ended December 31, 2020. Second Quarter 2021 Highlights All...

6 months ago - Business Wire

On Thursday, January 28, ResMed (NYSE:RMD) will release its latest earnings report. Decipher the announcement with Benzinga's help.

6 months ago - Benzinga

Telemedicine is here to stay as the new coronavirus strain triggers a fear psychosis at large, thereby retaining solid demand for telehealth stocks.

Other stocks mentioned: AMWL, TDOC, UNH
6 months ago - Zacks Investment Research

QDEL vs. RMD: Which Stock Is the Better Value Option?

Other stocks mentioned: QDEL
6 months ago - Zacks Investment Research

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind device to reduce the cost and complexity of dialysis, is bols...

Other stocks mentioned: OM
6 months ago - Business Wire

About RMD

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, di... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Jun 2, 1995
CEO
Michael Farrell
Employees
7,770
Stock Exchange
NYSE
Ticker Symbol
RMD
Full Company Profile

Financial Performance

In 2020, ResMed's revenue was $2.96 billion, an increase of 13.44% compared to the previous year's $2.61 billion. Earnings were $621.67 million, an increase of 53.65%.

Financial Statements

Analyst Forecasts

According to 10 analysts, the average rating for ResMed stock is "Hold." The 12-month stock price forecast is 228.33, which is a decrease of -15.99% from the latest price.

Price Target
$228.33
(-15.99% downside)
Analyst Consensus: Hold